We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+2.67%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.66%
AUM
$1.01B
AUM Growth
+$217M
(+27%)
Cap. Flow
+$212M
Cap. Flow
% of AUM
20.87%
Top 10 Holdings %
Top 10 Hldgs %
33.44%
Holding
2,859
New
220
Increased
1,610
Reduced
469
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$57.7M |
| 2 |
Broadcom
AVGO
|
+$13.4M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$10.3M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$9.41M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$8.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$1.27M |
| 2 |
Avantis International Equity ETF
AVDE
|
+$1.24M |
| 3 |
AstraZeneca
AZN
|
+$1.1M |
| 4 |
GREK
Global X MSCI Greece ETF
GREK
|
+$1.07M |
| 5 |
HIMU
iShares High Yield Muni Active ETF
HIMU
|
+$779K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Financials | 6.8% |
| 3 | Industrials | 6.1% |
| 4 | Consumer Discretionary | 4.96% |
| 5 | Healthcare | 4.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
CareDx
CDNA
$2.47B
| $16.6K | ﹤0.01% |
958
+87
| +10% | +$1.65K |
|
1902
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.94B
| $16.6K | ﹤0.01% |
173
-237
| -58% | -$23.2K |
|
1903
REX American Resources
REX
$1.43B
| $16.6K | ﹤0.01% |
364
| – | – |
|
1904
Sabra Healthcare REIT
SBRA
$5.29B
| $16.6K | ﹤0.01% |
862
+162
| +23% | +$3.19K |
|
1905
Invesco S&P 500 Pure Value ETF
RPV
$1.72B
| $16.6K | ﹤0.01% |
154
+1
| +0.7% | +$109 |
|
1906
WaFd
WAFD
$2.74B
| $16.5K | ﹤0.01% |
527
+93
| +21% | +$2.99K |
|
1907
Henry Schein
HSIC
$9.82B
| $16.5K | ﹤0.01% |
224
+64
| +40% | +$4.94K |
|
1908
Herbalife
HLF
$1.22B
| $16.5K | ﹤0.01% |
1,118
+56
| +5% | +$915 |
|
1909
monday.com
MNDY
$3.69B
| $16.4K | ﹤0.01% |
238
-71
| -23% | -$6.81K |
|
1910
Preferred Bank
PFBC
$1.24B
| $16.4K | ﹤0.01% |
181
-17
| -9% | -$1.54K |
|
1911
Ivanhoe Electric
IE
$1.76B
| $16.4K | ﹤0.01% |
1,385
| – | – |
|
1912
EyePoint Inc
EYPT
$1.15B
| $16.4K | ﹤0.01% |
1,270
| – | – |
|
1913
Chewy
CHWY
$9.36B
| $16.4K | ﹤0.01% |
606
+395
| +187% | +$11K |
|
1914
Vanda Pharmaceuticals
VNDA
$298M
| $16.3K | ﹤0.01% |
2,362
| – | – |
|
1915
iShares S&P 100 ETF
OEF
$20.5B
| $16.2K | ﹤0.01% |
51
| – | – |
|
1916
HealthStream
HSTM
$865M
| $16.2K | ﹤0.01% |
782
+594
| +316% | +$12.6K |
|
|
FFWM
1917
DELISTED
First Foundation Inc
FFWM
| $16.2K | ﹤0.01% |
2,744
+351
| +15% | +$2.13K |
|
1918
Pathward Financial
CASH
$1.79B
| $16.2K | ﹤0.01% |
181
+13
| +8% | +$1.13K |
|
|
INVX
1919
Innovex International
INVX
$2.01B
| $16.1K | ﹤0.01% |
662
| – | – |
|
|
PPTA
1920
Perpetua Resources
PPTA
$3.12B
| $16.1K | ﹤0.01% |
574
| – | – |
|
1921
PAR Technology
PAR
$730M
| $16K | ﹤0.01% |
1,201
+773
| +181% | +$18.2K |
|
1922
RXO
RXO
$3.59B
| $16K | ﹤0.01% |
1,095
+143
| +15% | +$2.1K |
|
1923
Sweetgreen
SG
$644M
| $16K | ﹤0.01% |
3,080
+767
| +33% | +$4.66K |
|
1924
Brown & Brown
BRO
$23.8B
| $16K | ﹤0.01% |
245
+16
| +7% | +$1.15K |
|
1925
NewtekOne
NEWT
$374M
| $16K | ﹤0.01% |
1,459
+603
| +70% | +$7.65K |
|
Similar funds
FLAM
AIM
MTCM
CNC
RIM
C
HH
EIA
Versant Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Versant Capital Management held 2,859 positions worth $1.01B, up 27% from $797M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Versant Capital Management deployed $212M of net new capital in Q1 2026, opening 220 new positions and adding to 1,610 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $1.27M trimmed.
- Versant Capital Management's largest Q1 2026 buy was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
- Versant Capital Management added most to Microsoft in Q1 2026, an estimated $57.7M increase.
- Versant Capital Management's biggest Q1 2026 reduction was VanEck Gold Miners ETF, cutting an estimated $1.27M.
- Versant Capital Management fully exited AstraZeneca in Q1 2026, selling an estimated $1.1M.
- Versant Capital Management's ten largest holdings make up 33% of its $1.01B portfolio in Q1 2026.
- Versant Capital Management opened 220 new positions and closed 82 in Q1 2026.
- Versant Capital Management's portfolio value rose 27% quarter-over-quarter to $1.01B.
Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.